anticoagulants, low molecular weight heparins
DISEASE INTERVENTION COMPARISON RESULTS
Circulation. 1998 May 5;97(17):1702-7 Economic
IN anticoagulants, low molecular weight heparins The Use of

As coste
Is Than
To
Ann Intern Med. 1999 May 18;130(10):789-99 Cost-Effectiveness
IN thromboembolic disease, deep venous thrombosis, anticoagulants, low molecular weight heparins The Use of
heparin, low molecular weight
As Treatment, Acute, Cost
Is better Than
unfractionated heparin
To reduce total costs for inpatient treatment, but nor for outpatient treatment.
Chest. 2005 Sep;128(3):1601-10 Cost-Effectiveness
IN thromboembolic disease, pulmonary embolism, anticoagulants, low molecular weight heparins The Use of
heparin, low molecular weight
As Treatment, Acute
Is better Than
unfractionated heparin
To for impatients LMWH were only marginally more expensive (dollar 13,001 LMWH vs dollar 12,780 UFH) but yielded more QUALYs (7.677 QALYs vs 7.493 QALYs).